ID: ALA4204732

Max Phase: Preclinical

Molecular Formula: C34H34N4O6

Molecular Weight: 594.67

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(C)cc(C(=O)N[C@H](Cc2ccc(-c3c(CO)noc3C)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1

Standard InChI:  InChI=1S/C34H34N4O6/c1-19-12-20(2)14-24(13-19)32(40)36-28(15-22-8-10-23(11-9-22)31-21(3)44-38-30(31)18-39)33(41)37-29(34(42)43)16-25-17-35-27-7-5-4-6-26(25)27/h4-14,17,28-29,35,39H,15-16,18H2,1-3H3,(H,36,40)(H,37,41)(H,42,43)/t28-,29+/m1/s1

Standard InChI Key:  QZAWEGAXTRSLTC-WDYNHAJCSA-N

Associated Targets(Human)

Hemoglobin HbA 880 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 594.67Molecular Weight (Monoisotopic): 594.2478AlogP: 4.39#Rotatable Bonds: 11
Polar Surface Area: 157.55Molecular Species: ACIDHBA: 6HBD: 5
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.88CX Basic pKa: CX LogP: 4.52CX LogD: 1.30
Aromatic Rings: 5Heavy Atoms: 44QED Weighted: 0.15Np Likeness Score: -0.45

References

1. Goldstein SR, Liu C, Safo MK, Nakagawa A, Zapol WM, Winkler JD..  (2018)  Design, Synthesis, and Biological Evaluation of Allosteric Effectors That Enhance CO Release from Carboxyhemoglobin.,  (7): [PMID:30034606] [10.1021/acsmedchemlett.8b00166]

Source